Patents by Inventor Evan Thompson
Evan Thompson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11989394Abstract: Devices, methods and graphical user interfaces for manipulating user interfaces based on fingerprint sensor inputs are provided. While a display of an electronic device with a fingerprint sensor displays a first user interface, the device may detect movement of a fingerprint on the fingerprint sensor. In accordance with a determination that the movement of the fingerprint is in a first direction, the device allows navigating through the first user interface, and in accordance with a determination that the movement of the fingerprint is in a second direction different from the first direction, the device allows displaying a second user interface different from the first user interface on the display.Type: GrantFiled: November 12, 2021Date of Patent: May 21, 2024Assignee: Apple Inc.Inventors: Benjamin J. Pope, Daniel W. Jarvis, Nicholas G. Merz, Scott A. Myers, Michael A. Cretella, Michael Eng, James H. Foster, Terry L. Gilton, Myra Haggerty, Byron B. Han, M. Evans Hankey, Steven P. Hotelling, Brian R. Land, Stephen Brian Lynch, Paul Meade, Mushtaq A. Sarwar, John P. Ternus, Paul M. Thompson, Marcel Van Os, John A. Wright
-
Patent number: 11980709Abstract: A fat harvesting systems and related methods of harvesting and reinjecting fat that provides a medical professional with multiple technique options. Harvested fat can be subjected to a variety of pre-reinjection preparation steps within a single, self contained reservoir such that the potential for contaminating the harvested fat is avoided. The fat harvesting system can be completely self-contained kit requiring no additional external systems or alternatively, can utilize available surgical suite systems, for example, vacuum to successfully harvest, prepare and reinject fat cells. The fat harvesting system can size harvested fat cells so as to be especially desirable for different injection locations in the body. The fat harvesting system is a single use, disposable system that requires no sterilization equipment and recovered and sized fat cells are maintained in a sanitary environment so as to avoid contamination that could result in having to discard recovered fat cells.Type: GrantFiled: May 5, 2023Date of Patent: May 14, 2024Assignee: Chopra Gryskiewicz, LLCInventors: Karan Chopra, Joseph M. Gryskiewicz, Richard A. Thompson, Reed O. Saunders, Evan M. Leingang, Thomas A. Tedham, Mohamed A. Mohamed, Jacob T. Wilson, Brett J. Herdegen, Jason N. Scherer, Landon Hove Dinger, Justin A. Barbot
-
Publication number: 20240107229Abstract: A smart speaker power controller may be configured to receive power conforming to one of a plurality of power modes from an input power source. The power controller may be further configured to communicate the power mode to at least one component of a processing system or at least one component of an audio system for operating the smart speaker according to the received power mode, including determining a current limit of a power converter; determining a shutdown voltage threshold and safely shutting down the smart speaker if the input voltage falls below the threshold, and/or modifying audio operation of the smart speaker in response to the power mode. The smart speaker can further include an audio power supply controller configured to monitor energy required to reproduce an audio signal and to servo a power supply voltage provided to an audio amplifier in response to this energy level.Type: ApplicationFiled: December 11, 2023Publication date: March 28, 2024Inventors: Zhigang Dang, Daniel Naito, Evan Thompson, Peter Poon, Manasi Lagare, Michael Nussbaum, David Sumberg
-
Publication number: 20240090748Abstract: A system includes an endoscope connector and an endoscope adapter. The endoscope connector includes a first portion. The first portion includes a first magnetic coupling element and a first planar portion that is perpendicular to an axial direction of the endoscope connector. The endoscope adapter includes a second planar portion. The second planar portion includes a second magnetic coupling element and a substantially planar surface that is perpendicular to an axial direction of the endoscope adapter. The endoscope connector is non-mechanically attachable to the endoscope adapter using the first magnetic coupling element and the second magnetic coupling element. The first planar portion is alignable with the second planar portion such that: electroconductive contacts of the endoscope connector are axially aligned with electroconductive pins of the endoscope adapter and a port of the endoscope connector is axially aligned with a corresponding insertion port of the endoscope adapter.Type: ApplicationFiled: November 27, 2023Publication date: March 21, 2024Inventors: Anina COOTER, Michael KLOTER, Evan M. LEINGANG, Kevin R. LOCHNER, Indrek-Toomas POLLUKS, Marko RADOSEVIC, Jeremy ROTH, Reed O. SAUNDERS, Thomas A. TEDHAM, Richard A. THOMPSON, II, Chase VAN ROSSEN
-
Patent number: 11910171Abstract: A smart speaker power controller may be configured to receive power conforming to one of a plurality of power modes from an input power source. The power controller may be further configured to communicate the power mode to at least one component of a processing system or at least one component of an audio system for operating the smart speaker according to the received power mode, including determining a current limit of a power converter; determining a shutdown voltage threshold and safely shutting down the smart speaker if the input voltage falls below the threshold, and/or modifying audio operation of the smart speaker in response to the power mode. The smart speaker can further include an audio power supply controller configured to monitor energy required to reproduce an audio signal and to servo a power supply voltage provided to an audio amplifier in response to this energy level.Type: GrantFiled: December 4, 2020Date of Patent: February 20, 2024Assignee: Apple Inc.Inventors: Zhigang Dang, Daniel Naito, Evan Thompson, Peter Poon, Manasi Lagare, Michael Nussbaum, David Sumberg
-
Patent number: 11339222Abstract: A method of treating a subject can include administering to a subject in need thereof an effective amount of a killer cell lectin-like receptor G1 (KLRG1)/ligand binding agent, thereby disrupting KLRG1 signaling and activating CD8+ cytotoxic T and/or NK cells. A method of treating cancer can include administering to a subject in need thereof an effective amount of a killer cell lectin-like receptor G1 (KLRG1)/ligand binding agent. The methods can treat various cancers, for example melanoma, lung cancer, pancreatic cancer, glioma, breast cancer, and ovarian cancer.Type: GrantFiled: June 2, 2017Date of Patent: May 24, 2022Assignee: THE BRIGHAM AND WOMEN'S HOSPITAL, INC.Inventors: Steven Greenberg, Stefano Vincenzo Gulla, Kenneth Evan Thompson
-
Publication number: 20220089747Abstract: The receptor killer cell lectin-like receptor G1 (KLRG1) is expressed on T and NK cells, which binds to ligands on epithelial and mesenchymal cells. The ligand for KLRG1 has been described to be E-cadherin, N-cadherin, and R-cadherin. The present disclosure relates to and results from the discovery and characterization of antibodies that bind the extracellular domain (ECD) of KLRG1 but do not interfere with its interaction with the ligands E-cadherin, N-cadherin, and R-cadherin. The antibodies described have been derived by mouse hybridoma technology, and can be humanized by grafting their complementary determining regions (CDRs) into a human framework. The antibodies described can be used as effective therapeutic agents. Various antibodies, or antigen-binding fragments of such antibodies, along with various therapeutic and/or diagnostic methods, among other features, are provided for in the present disclosure.Type: ApplicationFiled: October 20, 2021Publication date: March 24, 2022Inventors: Stefano Vincenzo Gulla, Kenneth Evan Thompson
-
Publication number: 20220078548Abstract: A smart speaker power controller may be configured to receive power conforming to one of a plurality of power modes from an input power source. The power controller may be further configured to communicate the power mode to at least one component of a processing system or at least one component of an audio system for operating the smart speaker according to the received power mode, including determining a current limit of a power converter; determining a shutdown voltage threshold and safely shutting down the smart speaker if the input voltage falls below the threshold, and/or modifying audio operation of the smart speaker in response to the power mode. The smart speaker can further include an audio power supply controller configured to monitor energy required to reproduce an audio signal and to servo a power supply voltage provided to an audio amplifier in response to this energy level.Type: ApplicationFiled: December 4, 2020Publication date: March 10, 2022Inventors: Zhigang Dang, Daniel Naito, Evan Thompson, Peter Poon, Manasi Lagare, Michael Nussbaum, David Sumberg
-
Patent number: 11180561Abstract: The receptor killer cell lectin-like receptor G1 (KLRG1) is expressed on T and NK cells, which binds to ligands on epithelial and mesenchymal cells. The ligand for KLRG1 has been described to be E-cadherin, N-cadherin, and R-cadherin. The present disclosure relates to and results from the discovery and characterization of antibodies that bind the extracellular domain (ECD) of KLRG1 but do not interfere with its interaction with the ligands E-cadherin, N-cadherin, and R-cadherin. The antibodies described have been derived by mouse hybridoma technology, and can be humanized by grafting their complementary determining regions (CDRs) into a human framework. The antibodies described can be used as effective therapeutic agents. Various antibodies, or antigen-binding fragments of such antibodies, along with various therapeutic and/or diagnostic methods, among other features, are provided for in the present disclosure.Type: GrantFiled: April 9, 2020Date of Patent: November 23, 2021Assignee: Abcuro, Inc.Inventors: Stefano Vincenzo Gulla, Kenneth Evan Thompson
-
Publication number: 20210347899Abstract: The invention relates to antibodies, or antigen-binding fragments thereof, that specifically binds to killer cell lectin-like receptor G1 (KLRG1). Such antibodies, or antigen-binding fragments thereof, are useful for various therapeutic or diagnostic purposes including treatment of cancers and to increase the effectiveness of vaccines.Type: ApplicationFiled: September 6, 2019Publication date: November 11, 2021Inventors: Stefano V GULLA, Kenneth Evan THOMPSON
-
Publication number: 20190292264Abstract: A method of treating a subject can include administering to a subject in need thereof an effective amount of a killer cell lectin-like receptor G1 (KLRG1)/ligand binding agent, thereby disrupting KLRG1 signaling and activating CD8+ cytotoxic T and/or NK cells. A method of treating cancer can include administering to a subject in need thereof an effective amount of a killer cell lectin-like receptor G1 (KLRG1)/ligand binding agent. The methods can treat various cancers, for example melanoma, lung cancer, pancreatic cancer, glioma, breast cancer, and ovarian cancer.Type: ApplicationFiled: June 2, 2017Publication date: September 26, 2019Inventors: Steven Greenberg, Stefano Vincenzo Gulla, Kenneth Evan Thompson
-
Patent number: 10406545Abstract: A fluid delivery system for dispensing fluid can include a dispenser, such as a trigger engine-type dispenser, configured to draw fluid up from a container. A nozzle assembly can include a nozzle, and a nozzle slide. The nozzle slide can be configured to slide and/or rotate relative to the shroud to provide different dispensing modes. In alternative examples, the nozzle can be configured to rotate in 30 degree increments relative to the shroud to provide the different dispensing modes or the nozzle assembly can include a nozzle extension, and the nozzle extension can be configured to rotate relative to the shroud to provide different dispensing patterns out of the nozzle. In another example a first nozzle can be configured to provide one or more dispensing modes, and a second nozzle can be configured to provide a different dispensing mode than the first nozzle. Methods of dispensing fluids and methods of assembling fluid dispensers are also disclosed.Type: GrantFiled: November 8, 2017Date of Patent: September 10, 2019Assignee: S. C. Johnson & Son, Inc.Inventors: Ronald H. Spang, Jr., Matthew T. Mcdonnell, David Leifheit, Cory J. Nelson, Matthew Thurin, Philip Anthony, III, Aaron Eiger, Evan Thompson, Douglas A. Soller
-
Patent number: 10410513Abstract: A motor vehicle system for generating and transmitting motor vehicle imaging object data includes a communication system module positioned in a host vehicle receiving vehicle attribute data during host vehicle highway travel and preparing a fused object attribute data for transmission. An imaging device collects object imaging data representing objects within a visible detection range of the imaging device. An object detection and classification system module has an object classification sub-module used to classify the objects within the visible detection range as a vehicle type or a pedestrian and to output each as an object attribute data. A target fusion module receives the object attribute data from the object detection and classification system module, fuses the object attribute data with the vehicle attribute data to create the fused object attribute data, and forwards the fused object attribute data to the communication system module for transmission.Type: GrantFiled: June 30, 2016Date of Patent: September 10, 2019Assignee: DURA OPERATING, LLCInventors: Donald Raymond Gignac, Aaron Evans Thompson, Danish Uzair Siddiqui, Rajashekhar Patil, Gordon M. Thomas
-
Publication number: 20190194333Abstract: A method of treating a subject can comprise administering to a subject in need thereof an effective amount of a killer cell lectin-like receptor G1 (KLRG1) depleting agent, thereby depleting CD8+ cytotoxic T and/or NK cells in vivo. A method of treating a subject can comprise administering to a subject in need thereof an effective amount of a KLRG1 depleting agent with effector killing function. A composition, for example an anti-KLRG1 antibody, can comprise a KLRG1 depleting agent. The methods and compositions can be used for various diseases in which KLRG1 is overexpressed, for example autoimmune diseases, transplant rejection, hematologic malignancies, and solid tumors.Type: ApplicationFiled: September 15, 2017Publication date: June 27, 2019Inventors: Steven Greenberg, Stefano Vincenzo Gulla, Kenneth Evan Thompson
-
Patent number: 10282997Abstract: A method of generating and communicating lane information from a host vehicle to a vehicle-to-vehicle (V2V) network includes collecting visual data from a camera, detecting a lane within the visual data, generating a lane classification for the lane based on the visual data, assigning a confidence level to the lane classification, generating a lane distance estimate from the visual data, generating a lane model from the lane classification and the lane distance estimate, and transmitting the lane model and the confidence level to the V2V network.Type: GrantFiled: June 30, 2016Date of Patent: May 7, 2019Assignee: DURA OPERATING, LLCInventors: Donald Raymond Gignac, Aaron Evans Thompson, Danish Uzair Siddiqui, Rajashekhar Patil, Gordon M. Thomas
-
Publication number: 20190085083Abstract: A method of treating a subject can include administering to a subject in need thereof an effective amount of a killer cell lectin-like receptor G1 (KLRG1)/ligand binding agent, thereby disrupting KLRG1 signaling and activating CD8+ cytotoxic T and/or NK cells. A method of treating cancer can include administering to a subject in need thereof an effective amount of a killer cell lectin-like receptor G1 (KLRG1)/ligand binding agent. The methods can treat various cancers, for example melanoma, lung cancer, pancreatic cancer, glioma, breast cancer, ovarian cancer, metastatic breast cancer, and colon cancer.Type: ApplicationFiled: November 28, 2018Publication date: March 21, 2019Inventors: Steven Greenberg, Stefano Vincenzo Gulla, Kenneth Evan Thompson
-
Patent number: 10053010Abstract: A system for displaying an image on a display device of a motor vehicle includes a rear-view camera connected to a moveable component on the motor vehicle and a controller in communication with the rear-view camera. The controller has memory for storing control logic and a processor configured to execute the control logic. The control logic includes capturing a field of view image from the rear-view camera, determining a position of the rear-view camera, determining an image perspective relationship of the field of view image based on the position of the rear-view camera, modifying the field of view image based on the image perspective relationship to create a virtual perspective image, and displaying the virtual perspective image on the display device in the motor vehicle as the position of the rear-view camera changes between at least a first position and a second position.Type: GrantFiled: December 4, 2015Date of Patent: August 21, 2018Assignee: DURA OPERATING, LLCInventors: Aaron Evans Thompson, Benjamin Saltsman, Sean O'Rourke
-
Patent number: 9959765Abstract: A motor vehicle alert system based on vehicle dynamics input includes a communication module positioned in a host vehicle receiving and sending vehicle data in a vehicle mobility data format. A list generator in communication with the communication module generates the vehicle data as specific vehicle identification data in a track list to distinguish a sensed vehicle and at least one other vehicle positioned proximate the host vehicle. A tracker module in communication with the list generator periodically updates the vehicle data for the sensed vehicle and the at least one other vehicle. A transient condition data device generates data identifying when a transient condition of the sensed vehicle is present. A message standard conformance module receives the data identifying the transient condition and forwards the data identifying the transient condition to the communication module for transmission to the at least one other vehicle proximate to the host vehicle.Type: GrantFiled: June 30, 2016Date of Patent: May 1, 2018Assignee: DURA OPERATING LLCInventors: Aaron Evans Thompson, Donald Raymond Gignac, Danish Uzair Siddiqui, Rajashekhar Patil, Gordon M. Thomas
-
Publication number: 20180065132Abstract: A fluid delivery system for dispensing fluid can include a dispenser, such as a trigger engine-type dispenser, configured to draw fluid up from a container. A nozzle assembly can include a nozzle, and a nozzle slide. The nozzle slide can be configured to slide and/or rotate relative to the shroud to provide different dispensing modes. In alternative examples, the nozzle can be configured to rotate in 30 degree increments relative to the shroud to provide the different dispensing modes or the nozzle assembly can include a nozzle extension, and the nozzle extension can be configured to rotate relative to the shroud to provide different dispensing patterns out of the nozzle. In another example a first nozzle can be configured to provide one or more dispensing modes, and a second nozzle can be configured to provide a different dispensing mode than the first nozzle. Methods of dispensing fluids and methods of assembling fluid dispensers are also disclosed.Type: ApplicationFiled: November 8, 2017Publication date: March 8, 2018Inventors: Ronald H. Spang, JR., Matthew T. Mcdonnell, David Leifheit, Cory J. Nelson, Matthew Thurin, Philip Anthony, III, Aaron Eiger, Evan Thompson, Douglas A. Soller
-
Patent number: 9839927Abstract: A fluid delivery system for dispensing fluid can include a dispenser, such as a trigger engine-type dispenser (100), configured to draw fluid up from a container. A nozzle assembly can include a nozzle (160), and a nozzle slide (112). The nozzle slide can be configured to slide and/or rotate relative to the shroud (102) to provide different dispensing modes. In alternative examples, the nozzle (160) can be configured to rotate in 30 degree increments relative to the shroud (102) to provide the different dispensing modes or the nozzle assembly can include a nozzle extension, and the nozzle extension can be configured to rotate relative to the shroud to provide different dispensing patterns out of the nozzle. In another example a first nozzle can be configured to provide one or more dispensing modes, and a second nozzle can be configured to provide a different dispensing mode than the first nozzle. Methods of dispensing fluids and methods of assembling fluid dispensers are also disclosed.Type: GrantFiled: March 6, 2014Date of Patent: December 12, 2017Assignee: S. C. Johnson & Son, Inc.Inventors: Ronald H. Spang, Matthew T. Mcdonnell, David Leifheit, Cory J. Nelson, Matthew Thurin, Philip Anthony, III, Aaron Eiger, Evan Thompson, Douglas A. Soller